Objectives: describe precisely how to translate anatomical dissections in clinical anatomy in off label areas for injection of BoNT-A

Introduction: Botulinum toxin A is injected more and more in many areas of the face and body not approved and so totally off label.

Materials / method: in the presentation it is highlighted how to study patients movements to understand exactly the insertion of mimetic muscles especially in the lower third of the face. Some patients have been studied and are then presented to check insertions of mimetic muscles and so decide the points of injection and units to relax them. It is a case history of clinical anatomical study

Results: results are shown in some patients of the case history after 15 days and possible improvements are proposed

Conclusion: clinical anatomy is crucial to understand mimetic muscle anatomy and then decide exacly what muscle, what part of the muscle how many units use according to differences present in all patients

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: how to use and what to expect from the results of using botulinum toxin for the treatment of rosacea

Conclusion: how to use and what to expect from the results of using botulinum toxin for the treatment of rosacea

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Since 1977 botulinum toxin has been used in an increasing number of therapeutic indications now extending to the field of androsexology.

Introduction: For the past decade, a large number of publications based on retrospective or controlled studies have highlighted the interest in using botulinum toxin in intracavernous injections to treat erectile dysfunction.

Materials / method: This treatment is used either as monotherapy or in combination with oral treatments already established if they prove insufficient. It is by inhibiting the adrenergic and cholinergic pathways that the toxin promotes erection.

Results: The facilitative effect on erection lasts more than 6 months after injection as we have clinically proven successfully, confirming the tests published elsewhere: IIEF, SHIM and EHS. Here we describe the technique of injections.
Even if this indication is an off-label use, botulinum toxin, because of its efficacy and its inocuity can be offered to patients resistant to IPDE5, avoiding them to switch to second-line treatments, more restrictive, which are intracavernous injections of prostaglandin E1 to be performed before each sexual intercourse.

Conclusion: Further work is however needed to establish more precise protocols, including toxin type, doses and frequency of injections.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability